SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Sales for the quarter ended December 2023 of Rs. 3.26 million declined by -73.19% from Rs. 12.16 millions.The Net Loss for the quarter ended December 2023 is Rs. -6.51 millions as compared to Net Profit of Rs. 16.18 millions of corresponding quarter ended December 2022Operating profit Margin for the quarter ended December 2023 slipped to -3.01% as compared to 16.71% of corresponding quarter ended December 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 3.26 12.16 -73.19 28.26 33.36 -15.29 37.07 1.27 2818.90
Other Income 13.27 27.89 -52.42 44.73 71.89 -37.78 105.34 395.35 -73.36
PBIDT -3.01 16.71 -118.01 -16.36 33.28 -149.16 53.76 339.68 -84.17
Interest 0.56 0.17 229.41 1.25 0.58 115.52 1.07 2.47 -56.68
PBDT -3.57 16.54 -121.58 -17.61 32.27 -154.57 44.81 36.44 22.97
Depreciation 0.28 0.34 -17.65 0.86 1.19 -27.73 1.45 1.92 -24.48
PBT -3.85 16.20 -123.77 -18.47 31.08 -159.43 43.36 34.52 25.61
TAX 2.66 0.02 13200.00 2.66 1.13 135.40 2.26 4.96 -54.44
Deferred Tax 2.66 0.02 13200.00 2.66 1.13 135.40 2.26 7.46 -69.71
PAT -6.51 16.18 -140.23 -21.13 29.95 -170.55 41.10 29.56 39.04
Equity 766.33 766.33 0.00 766.33 766.33 0.00 766.33 766.33 0.00
PBIDTM(%) -92.33 137.42 -167.19 -57.89 99.76 -158.03 145.02 26746.46 -99.46

Ambalal Sarabhai Ent Share Price

31.07 -0.26 (-0.83%)
06-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.40
Dr. Reddys Lab 1310.50
Cipla 1365.25
Zydus Lifesciences 939.10
Lupin 2442.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×